74 results
Page 2 of 4
6-K
EX-99.1
uf9ang x7o7d
9 Aug 23
SciSparc Ltd. Announces Proposed Underwritten Public Offering of Approximately $1.3 Million
7:30pm
6-K
EX-99.1
0o55s0hftt70cru0
2 Aug 23
Report of Foreign Private Issuer
12:00am
6-K
EX-99.1
q4kmo
16 Jun 23
Report of Foreign Private Issuer
9:09am
6-K
EX-10.3
1r2or
4 Apr 23
SciSparc completes the sale of a 49% interest in its Subsidiary that owns Wellution for $3 million
7:07am
6-K
EX-99.3
09q0is 06
30 Sep 22
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
7:27am
6-K
EX-99.1
jgjcfc5vpni
11 Aug 22
Current Report
4:05pm
6-K
EX-99.1
qinoexz esvfjh61
7 Jul 22
Report of Foreign Private Issuer
4:00pm
6-K
EX-99.1
w8a8hsu6wc763ip
24 Jun 22
SciSparc Announces Ethics Committee Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
8:52am
6-K
EX-99.4
z8zzutwkm6z6nlbenh
27 May 22
SciSparc Announces Pricing of $10 Million Private Placement Priced At-the-Market
4:10pm
6-K
spn80c
22 Feb 22
Report of Foreign Private Issuer
9:05am
6-K
EX-99.1
s8a1w45
4 Jan 22
SciSparc Issued U.S. Patent For Its Core Technology That Treats Central Nervous Systems Disorders
4:42pm
POS AM
bgxfbobzt
8 Oct 21
Prospectus update (post-effective amendment)
12:00am
POS AM
2kbzr9huuisxnl9
27 Aug 21
Prospectus update (post-effective amendment)
12:00am
POS AM
rx1d6w44uoo zo7f3oz
27 Aug 21
Prospectus update (post-effective amendment)
12:00am
F-1/A
28qzhurt
28 Apr 21
Registration statement (foreign) (amended)
4:38pm
F-1
7pt j74nlartbfbq
21 Apr 21
Registration statement (foreign)
4:17pm
POS AM
ryl3ibs46vf1j3wbu d0
31 Mar 21
Prospectus update (post-effective amendment)
12:00am
POS AM
i277ejl d0
31 Mar 21
Prospectus update (post-effective amendment)
12:00am